Better therapy for patients with heart failure and atrial fibrillation (CABA-HFPEF-DZHK27 trial)

The study “CABA-HFPEF-DZHK27” (CAtheter-Based Ablation of atrial fibrillation vs. conventional treatment in patients with Heart Failure with Preserved Ejection Fraction) is aiming for a better therapy for patients with heart failure and atrial fibrillation. Charité (Berlin, Germany) has the overall responsibility for the study. This trial is supported by German Centre for Cardiovascular Research (DZHK). Further information can be found in the press release (german only). 

8th AFNET/EHRA Consensus Conference 2021 Paper published

Posts NEWS Mon, 08.08.2022 8th AFNET/EHRA Consensus Conference 2021 Paper published The 8th AFNET/EHRA Consensus Conference Paper 2021 “Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation” has been published: https://academic.oup.com/europace/advance-article/doi/10.1093/europace/euac062/6650662  

EAST-AFNET 4 @ ESC 2022

Posts NEWS Thu, 07.07.2022 EAST-AFNET 4 @ ESC 2022 The newest subanalysis of the EAST-AFNET 4 study will be presented at this year’s ESC congress 2022 in Barcelona: Latest science in atrial fibrillationPredictors and mediators of improved outcomes on early rhythm control an analysis of the EAST AFNET – 4 data set.Monday, 29th of August … Read more

EAST-AFNET 4 @ EHRA 2022

The latest results of the EAST-AFNET 4 study will be presented at this year’s EHRA congress 2022:

Late Breaking Clinical Trials II
Atrial fibrillation – News on ablation and sex differences
Monday, 4th of April 2022 | 6:15 pm – 7:15 pm (CEST), Room 1
Session chaired by Tatjana Potpara
More information

EAST-AFNET 4 @ ESC Congress 2021

The latest results of the EAST – AFNET 4  study will be presented at this year’s ESC Congress 2021 (streamed live):

Late Breaking Science in Arrhythmias
Benefit of early rhythm control therapy in patients with asymptomatic AF -insights from EAST-AFNET 4
Friday, 27th of August 2021 | 10.30am – 11:15am (CEST)
Presented by Prof. Dr. Stephan Willems

EAST-AFNET 4 @ ESC Congress 2021

Die neuesten Ergebnisse der EAST-AFNET 4 Studie werden auf dem diesjährigen ESC Congress 2021 als Live-Stream präsentiert:

Late Breaking Science in Arrhythmias
Benefit of early rhythm control therapy in patients with asymptomatic AF -insights from EAST-AFNET 4
27.08.2021 | 10:30 – 11:15 Uhr (CEST)
Präsentiert von Prof. Dr. Stephan Willems

EAST-AFNET 4 @ HRS 2021

The latest results of the EAST – AFNET 4  study will be presented at this year’s HRS in Boston.

Early Rhythm Control Therapy In Patients With Atrial Fibrillation And Heart Failure (PD Dr. Andreas Rillig)
Live-Stream from the Heart Rhythm Society (HRS 2021), Boston, USA.
Friday, 30 July 2021
10:45am – 10:53am Eastern time / 4:45pm – 4:53pm CEST
More information

Early Rhythm Control for the Treatment of Atrial Fibrillation (Prof. Dr. Paulus Kirchhof)
Live-Stream from the Heart Rhythm Society (HRS 2021), Boston, USA.
Friday, 30 July 2021
1:30pm – 2:30pm Eastern time / 7:30pm – 8:30pm CEST
More information

EAST-AFNET 4 @ HRS 2021

The latest results of the EAST – AFNET 4  study will be presented at this year’s HRS in Boston.

Early Rhythm Control Therapy In Patients With Atrial Fibrillation And Heart Failure (PD Dr. Andreas Rillig)
Live-Stream from the Heart Rhythm Society (HRS 2021), Boston, USA.
Friday, 30 July 2021
10:45am – 10:53am Eastern time / 4:45pm – 4:53pm CEST